Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 4/20 | 0.41 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.33 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL641726 | 0.97 | SMPD1 (0.43) | FDPSSMPD1OPRM1TSHRTHRB | |
| SCHEMBL4260580 | 0.97 | SMPD1 (0.43) | FDPSSMPD1OPRM1TSHRTHRB | |
| SCHEMBL3073022 | 0.97 | SMPD1 (0.43) | FDPSSMPD1OPRM1TSHRTHRB | |
| SCHEMBL504337 | 0.92 | FDPS (0.39) | FDPSSMPD1OPRM1TSHRTHRB | |
| Ammonia Solution, Strong SCHEMBL28391001 | 0.90 | FDPS (0.38) | FDPSSMPD1OPRM1TSHR | |
| SCHEMBL640974 | 0.80 | FDPS (0.35) | FDPS | |
| SCHEMBL7036676 | 0.80 | FDPS (0.43) | FDPSSMPD1OPRM1GGPS1SPHK1 | |
| SCHEMBL27863382 | 0.79 | NFKB1 (0.37) | FDPSTSHRDNM1MEN1KMT2A | |
| SCHEMBL28732851 | 0.79 | FDPS (0.41) | FDPSSMPD1OPRM1TSHRTHRB | |
| SCHEMBL14277926 | 0.78 | FDPS (0.34) | FDPSOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118044612-A | Preparation method of ginsenoside ester health product | 南昌大学 | 2024-05-17 | — | — | CN | claimed |
| CN-114195784-A | Pabociclib related substance, preparation method and application thereof | 斯坦德标准技术研究(湖北)有限公司 | 2022-03-18 | — | — | CN | claimed |
| CN-110684083-A | Conjugate II for inhibiting melanin synthesis and application thereof in medicines and cosmetics | 北京岳昊科技发展有限公司 | 2020-01-14 | — | — | CN | claimed |
| CN-110680928-A | Conjugate for inhibiting melanin synthesis and application thereof in medicines and cosmetics | 北京岳昊科技发展有限公司 | 2020-01-14 | — | — | CN | claimed |
| US-12077631-B2 | Bulk polymerisation of polyoxazolidone | BASF SE (DE) | 2024-09-03 | — | — | US | disclosed |
| CN-118044612-A | Preparation method of ginsenoside ester health product | 南昌大学 | 2024-05-17 | — | — | CN | disclosed |
| CN-112424253-B | Bulk polymerization of polyoxazolidinones | 巴斯夫欧洲公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-117024516-A | Polypeptide mimic enzyme, preparation method thereof and application thereof in preparation of nerve substance detection reagent | 天津大学 | 2023-11-10 | — | — | CN | disclosed |
| CN-114106205-B | Preparation of mesenchymal stem cell exosomes and compositions and application in cosmetics | 滨州医学院 | 2023-10-10 | — | — | CN | disclosed |
| CN-110615826-B | Cosmetic composition and pharmaceutical composition | 因科斯医药公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-112041367-B | Aqueous composition containing uretdione groups and process for preparing the same | 科思创知识产权两合公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-111886272-B | Aqueous composition containing uretdione groups and process for its preparation | 科思创德国股份有限公司 | 2022-11-15 | — | — | CN | disclosed |
| US-20070129488-A1 | Preparation of a polyurethane dispersion with blocked isocyanate groups | BAYER MATERIALSCIENCE AG | 2007-06-07 | — | — | US | disclosed |
| US-20070095645-A1 | Distillation of ionic liquids | BASF AKTIENGESELLSCHAFT (DE) | 2007-05-03 | — | — | US | disclosed |
| US-20070032594-A1 | Self-crosslinking polyurethane dispersions containing uretdione and isocyanate-reactive groups | BAYER MATERIALSCIENCE AG | 2007-02-08 | — | — | US | disclosed |
| US-20070004856-A1 | Self-crosslinking polyurethane dispersions and a process for their preparation | BAYER MATERIALSCIENCE AG | 2007-01-04 | — | — | US | disclosed |
| US-7049367-B2 | Stoving enamels; use in varnishes and paints, especially in automotive coatings; gloss, smoothness | BAYER AKTIENGESELLSCHAFT (DE) | 2006-05-23 | — | — | US | disclosed |
| US-20050075470-A1 | Self-crosslinking polyurethane dispersions | BAYER MATERIALSCIENCE AG (DE) | 2005-04-07 | — | — | US | disclosed |
| US-20050020857-A1 | Removal by salt formation | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-27 | — | — | US | disclosed |
| US-20030199632-A1 | Self-crosslinking PU dispersions | BAYER AKTIENGESELLSCHAFT (DE) | 2003-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020857-A1 | Removal by salt formation | PHOSPHO1, AASDHPPT, INPP5B | FDPS 1434/4885SMPD1 297/4885OPRM1 4835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.